Ryosuke Satomi

Activation of the FGF2-FGFR1 Autocrine Pathway: A Novel Mechanism of Acquired Resistance to Gefitinib in NSCLC

Hideki Terai, Kenzo Soejima, Hiroyuki Yasuda et al. · Molecular Cancer Research · 2013 · 208 citations

Medicine, Oncology, Pharmacology +17

Inhibition of stearoyl-CoA desaturase 1 (SCD1) enhances the antitumor T cell response through regulating β-catenin signaling in cancer cells and ER stress in T cells and synergizes with anti-PD-1 antibody

Yuki Katoh, Tomonori Yaguchi, Akiko Kubo et al. · Journal for ImmunoTherapy of Cancer · 2022 · 103 citations · Full text

Medicine, Cancer Biology, Cancer Immunology +16

DOCK2 is involved in the host genetics and biology of severe COVID-19

Ho Namkoong, Ryuya Edahiro, Tomomi Takano et al. · Nature · 2022 · 97 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity

Ryuya Edahiro, Yuya Shirai, Yusuke Takeshima et al. · Nature Genetics · 2023 · 69 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma

Junko Hamamoto, Kenzo Soejima, Satoshi Yoda et al. · Molecular Medicine Reports · 2013 · 62 citations · Full text

Medicine, Molecular Biology, Oncology +17